4//SEC Filing
Rosenberg Noah L. 4
Accession 0001209191-21-048494
CIK 0001438533other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 4:09 PM ET
Size
5.4 KB
Accession
0001209191-21-048494
Insider Transaction Report
Form 4
Rosenberg Noah L.
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-07-28$13.81/sh−1,250$17,263→ 44,521 total
Footnotes (2)
- [F1]The sales reported were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F2]Includes 177 shares of the Issuer's common stock acquired by the reporting person on May 31, 2021 pursuant to an employee stock purchase program.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001579649
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 4:09 PM ET
- Size
- 5.4 KB